EPIDYOLEX · GWEP21042

Prospective observational study designed to monitor the long-term safety of patients under treatment with Epidyolex®. The investigation places special emphasis on monitoring potential cases of drug-induced liver injury (DILI).

A Prospective, Observational Cohort Study to Assess Long-Term Safety in Patients Prescribed Epidyolex® with a Focus on Drug-induced Liver Injury (DILI)

Sponsor: JAZZ PHARMA

Phase: IV

Status: Follow-up

View clinical trials catalogue